Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) discusses real-time electrogram analysis for drivers of atrial fibrillation (RADAR) - a multi-center, FDA-IDE, clinical trial of persistent AF.
Filmed on site at HRS 2019 by Radcliffe Cardiology
1. What is the RADAR trial and what does it aim to answer?
2. How can the CMA software help to locate AF driver domains?
3. What are your findings to date?
4. What are the implications for the future of AF ablation?
Videography: Tom Green
Interviewer: Jonathan McKenna